期刊文献+

雌激素治疗局限性脑缺血和性别因素的影响

Effects of gender aud estradlol treatment on focal brain ischemia
下载PDF
导出
摘要 摘 要:目的 探讨雌激素对雄性大鼠和雌性大鼠局限性脑缺血的治疗作用和性别因素的影响。方法 应用局限性脑缺血动物模型。结果 实验1组实验大鼠阻断大脑中动脉(MCA)后的死亡率:正常雄鼠和雌鼠均为12.5%(2/16),去卵巢雌鼠为23.5%。冠状面的脑梗死范围(平均值±标准差):正常雌鼠为9.5%±1.0%,正常雄鼠为16.6%±1.6%(两者相比P<0.01),去卵巢雌鼠为16.0%±1.4%(与正常雌且相比P<0.01)。实验2组实验大鼠在阻断MCA 40min后给去卵巢雌鼠注射雌二醇(E2)或其溶液羟丙基-β-环右旋聚糖(HPCD)。HPCD治疗组死亡率为40%(4/10),雌激素治疗组为0%。脑梗死的范围:HPCD治疗组为19.3%±1、8%,雌激素治疗组为8.0%±1.2%(两者相比 P<0.01)。血清中雌激素含量:HPCD治疗组为 14.5±1.2pg/ml,雌激素治疗组为142.7±23.6pg/ml(两者相比 P<0.01)。结论 在 MCA阻断造成局限性脑缺血时,雌激素有保护脑缺血的作用。 Abstract: Objective This paper was undertaken to investigate the effects of gender and estrogen treatment on focal cerebral ischemia in male and female rats. Methods Focal brain ischemia animal model was used. Results In first study, the mortalities from middle cerebral artery(MCA) occlusion were 12. 5% each for intact male and intact female rats, and 23. 5% for ovariectomized (OVX) female rats. The coronal infarct area was 9. 5%?. 0% for intact female rats,16. 6%?. 6% for intact male rats (P<0. 01 vs. intact female rats),and 16. 0%?. 4% for OVX female rats (P<0. 01vs. intact female rats). In second experiment, OVX-female rats were administrated either 17B-estradiol (E2) or its vehicle, hydroxypropyl-B-cyclodextrin (HPCD), at 40 min after the onset of MCA occlusion. Mortalities were 40% for vehicle treated OVX rats and 0% for E2 treated OVX rats. The infarct area was 19. 3%?. 8% for vehicle treated rats vs. 8. 0%?. 2% for E2 treated OVX rats (P<0. 01). Conclusion These results strongly suggest that the level of circulating estrogens play an important role in protecting brain tissues against ischemia induced by MCA occlusion.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2002年第1期3-5,共3页 Journal of Apoplexy and Nervous Diseases
关键词 大脑中动脉阻断 雌激素 局限性脑缺血 性别因素 大鼠 影响 Middle cerebral artery occlusion Estrogen Ischemia Sex-dependent Rat
  • 相关文献

参考文献8

  • 1[1]Stampfer MJ,Colditz FA,Willett WC,et al. Postmenopausal estrogen therapy and cardiovascular disease:ten-year follow-up from the Nurses' Health Study[J]. N Engl J Med,1991,325:756-762.
  • 2[2]Finucane FF,Madans JH,Bush TL,et al. Decreased risk of stroke among postmenopausal hormone users:results from a national cohort[J]. Arch Intern Med,1993,153:73-79.
  • 3[3]Longa EZ,Weinstein PR,Carlson S,et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke,1989,20:84-91.
  • 4[4]Nagasawa H,Kyuya K. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion[J]. Stroke,1989,20:1037-1043.
  • 5[5]Simpkins JW,Singh M,Bishop J. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated woth Alzheimer's disease[J]. Neurobiol Aging,1994,15:195-197.
  • 6[6]Rahimy MH,Bodor N,Simpkins JW. A rapid sensitive method for the simultaneous quantitation of estradiol and estradiol conjugates in a variety of tissues: assay development and evaluation of the distribution on a brain- enhanced estradiol-chemical delivery system[J]. J Steroid Biochem,1989,33:179-187.
  • 7[7]Shi J,Simpkins JW. 17β-estradiol modulation of glucose transporter 1 (GLUT 1) expression in blood-brain barrier[J]. Am J Physiol,1997,272:1016-1022.
  • 8[8]Shi J,Zhang YQ,Simpkins JW. Effects of 17β-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rats[J]. Exp Brain Res,1997,117:200-206.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部